1. Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner. (August 2018) Authors: Amersfoort, J.; Schaftenaar, F.H.; Douna, H.; van Santbrink, P.J.; Kröner, M.J.; van Puijvelde, G.H.M.; Quax, P.H.A.; Kuiper, J.; Bot, I. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Oxldl-induced apoptotic dendritic cells as a novel therapy for atherosclerosis. Issue 1 (July 2015) Authors: Frodermann, V.; van Puijvelde, G.H.M.; Wierts, L.; Lagraauw, H.M.; Foks, A.; van Santbrink, P.J.; Bot, I.; Kuiper, J.; de Jager, S.C.A. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗